COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111

Clinical trial NCT04388826 · COMPLETED

Trial details

NCT number: NCT04388826
Sponsor: Veru Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Distress Syndrome, Adult

Start date: 2020-06-18
Primary completion: 2020-12-18
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.